Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Tadalafil NDC 71610-567 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table of data showing the difference between Tadalafil (a medication for erectile dysfunction) and a placebo in terms of blood pressure measurements. The table shows the difference in standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure, over time (in hours). However, the data is incomplete and not readable without additional context.*
This is a medication experiment involving tadalafil and doxazosin. Different doses of tadalafil and doxazosin were given at 8:00 AM to individuals, along with a placebo as a control variable. The experiment monitored systolic blood pressure changes over time. The results of the experiment are not provided.*
This is a graph showing the plasma concentration of Tadalafil in mcg/L over time in hours after administration of various doses of the drug. The graph includes a single 20mg dose, a single 5mg dose, and a once-daily 5mg dose following 5 consecutive days of administration. The concentration of plasma Tadalafil increases over time and peaks at different levels depending on the dosage.*
This is a graph that shows the change from baseline in IPSS total score for two treatment groups over the course of a certain number of weeks. One group was treated with tadalafil 5 mg and the other group was treated with a placebo. At the end of the treatment period, the difference in scores between the two groups was statistically significant with a p-value of less than 0.01. The duration of treatment in weeks is not specified.*
The text is a comparison of the effects of Tadalafil 5mg and placebo on IPSS total score. The data shows a significant improvement in IPSS total score for Tadalafil 5mg compared to placebo. The duration of treatment in weeks is not specified.*
The text represents a comparison of the effects of Tadalafil 5mg and a Placebo in the treatment of a medical condition. The data includes the change from the baseline in IPSS Total Score as the outcome measure. There is also a statistical value of "p<0.01" which indicates the level of significance. However, without additional information or context, the specific medical condition or study design is not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.